The Philadelphia Eagles have decided not to place quarterback Jalen Hurts on injured reserve despite his ongoing battle with a superficial blood clot. According to ESPN, the team has not even entertained discussions regarding IR for their star QB.

Going on IR would mean sidelining Hurts for a minimum of four weeks, a critical period for the team. Following their Week 4 loss to the Los Angeles Rams, Hurts sought treatment for his calf, prompting an ultrasound that revealed the blood clot after the team arrived in London for their matchup against the Jacksonville Jaguars.

The Eagles’ medical staff initially determined that Hurts could continue to play. However, a subsequent ultrasound indicated that the blood clot had shifted, potentially leading to more serious health issues. The timeline for Hurts' return hinges on guidance from his medical team, as both he and the organization prioritize his health.

Currently, Hurts is evaluating various treatment options, with the belief that the condition is manageable. The main treatment for blood clots typically involves blood thinners, which would prevent him from playing. While these medications are usually required for six weeks, minor clots might be treated with alternatives like anti-inflammatories.

With Hurts out this week against the Carolina Panthers, Tanner McKee will step in as the starting quarterback, while rookie Cole Payton serves as the backup.